Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Residue on Ignition / Sulphated Ash Method Development – V 2.0

Posted on By

Analytical Method Development: Residue on Ignition / Sulphated Ash Method Development – V 2.0

SOP for Residue on Ignition and Sulphated Ash Method Development in AMD Laboratory


Department Analytical Method Development
SOP No. SOP/AMD/048/2025
Supersedes SOP/AMD/048/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the procedure for developing and validating methods to determine inorganic residues (non-volatile

matter) present in pharmaceutical substances and excipients using Residue on Ignition (ROI) or Sulphated Ash techniques. The goal is to ensure accuracy, reproducibility, and regulatory compliance.

2. Scope

This SOP applies to the development and validation of methods for ROI/Sulphated Ash determination in drug substances, raw materials, excipients, and formulations in the AMD laboratory using muffle furnaces and sulphuric acid treatments as per compendial standards.

3. Responsibilities

  • Analytical Chemist: Carries out method development and performs ignition procedures.
  • Reviewer: Verifies weight recordings, furnacing cycles, and calculations.
  • QA: Reviews validation records and ensures compliance with USP/IP/Ph. Eur. specifications.
  • Head – AMD: Approves the final method and oversees adherence to regulatory protocols.
See also  Analytical Method Development: System Suitability Testing Parameters Design - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring that the ROI/Sulphated Ash method is developed, validated, and implemented in accordance with GMP and pharmacopeial guidelines.

5. Procedure

5.1 Method Selection

  1. Choose between:
    • Residue on Ignition (ROI): Dry ashing without sulphuric acid (used for organic compounds).
    • Sulphated Ash: Uses concentrated sulphuric acid for complete oxidation and destruction of organic matter.
  2. Refer to USP <281>, IP, or Ph. Eur. guidelines to identify appropriate method.
  3. Record the selected approach in Annexure-1: Method Development Strategy Sheet.

5.2 Equipment Qualification

  1. Ensure muffle furnace is:
    • Calibrated and qualified (temp accuracy ±10°C)
    • Fitted with a certified reference thermometer or data logger
  2. Verify analytical balance calibration and log the verification in lab records.

5.3 Sample Preparation

  1. Weigh 1–2 g of test sample accurately into a pre-ignited and tarred crucible.
  2. Record weight in Annexure-2: Sample Weight and ROI Log.
  3. For sulphated ash, moisten the sample with concentrated sulphuric acid (~1 mL) prior to ignition.

5.4 Ignition Procedure

  1. Place the crucible in a cool muffle furnace.
  2. Gradually raise temperature to 600 ± 25°C over 30 minutes to avoid splattering.
  3. Maintain the temperature for 2 hours or until white/grey ash is obtained.
  4. Cool the crucible in a desiccator for 30 minutes and weigh.
  5. Repeat ignition if carbon residue is still visible.

5.5 Calculation

Residue (%) = [(Weight of residue) / (Initial sample weight)] × 100
  1. Perform triplicate trials and calculate mean and RSD.
  2. Record data in Annexure-3: ROI/Sulphated Ash Calculation Sheet.

5.6 Method Optimization

  1. Evaluate:
    • Effect of drying temperature (e.g., 550°C vs 600°C)
    • Sample size and crucible type
    • Sulphuric acid pre-treatment efficacy
  2. Document all optimization trials in Annexure-4: Method Optimization Log.

5.7 Method Validation

  1. Validate using ICH Q2(R1) guidance:
  2. Precision: Triplicate analysis on same and different days; RSD ≤ 2.0%.
  3. Accuracy: Spike known inorganic residue and recover within 98–102%.
  4. Specificity: Show that ash originates from inorganic material.
  5. Robustness: Assess minor variation in temperature and ashing duration.
  6. Compile validation in Annexure-5: Validation Summary Report.

6. Abbreviations

  • ROI: Residue on Ignition
  • AMD: Analytical Method Development
  • RSD: Relative Standard Deviation
  • GMP: Good Manufacturing Practices
  • QA: Quality Assurance

7. Documents

  1. Method Development Strategy Sheet – Annexure-1
  2. Sample Weight and ROI Log – Annexure-2
  3. ROI/Sulphated Ash Calculation Sheet – Annexure-3
  4. Method Optimization Log – Annexure-4
  5. Validation Summary Report – Annexure-5

8. References

  • USP <281> – Residue on Ignition
  • IP 2022 – Sulphated Ash
  • Ph. Eur. – 2.4.14 Sulphated Ash
  • ICH Q2(R1) – Validation of Analytical Procedures
  • 21 CFR Part 211 – Laboratory Controls

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Method Development Strategy Sheet

Sample Method Type Pre-treatment Remarks Prepared By
Excipent-A Sulphated Ash H2SO4 Sticky material, requires acid digestion Ajay Verma

Annexure-2: Sample Weight and ROI Log

Date Sample Crucible No. Initial Wt (g) Residue Wt (g) Residue (%)
03/05/2025 API-X 001 1.005 0.012 1.19

Annexure-3: ROI/Sulphated Ash Calculation Sheet

Trial Initial Weight (g) Residue Weight (g) ROI (%) Analyst
1 1.005 0.012 1.19 Sunita Reddy

Annexure-4: Method Optimization Log

Parameter Condition Result Conclusion
Temp 550°C Residue = 1.40% Incomplete combustion
Temp 600°C Residue = 1.19% Complete ashing

Annexure-5: Validation Summary Report

Parameter Acceptance Criteria Results Status
Precision RSD ≤ 2% 1.4% Pass
Accuracy 98–102% 99.1% Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added optimization criteria and acid pre-treatment clarification Regulatory Inspection Readiness
See also  Analytical Method Development: Archiving Method Development Reports - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: API Manufacturing: SOP for IPC Training to Operators and Chemists – V 2.0
Next Post: Creams: SOP for Ensuring Uniformity of Content in Creams – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version